Recent Company News

• 12:00 AM ET Jun 23, 2025
  

  StreetAccount Summary - Trading higher/lower: Asia mid-morning

• 10:50 PM ET Jun 10, 2025
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 01:10 AM ET Jul 08, 2025
  

  UCB to present 15 abstracts from its targeted neurology portfolio at the European Pediatric Neurology Society (EPNS) Congress, Munich, Germany, July 8-12, 2025 (€169.90, 0.00)

• 09:05 AM ET Jun 24, 2025
  

  Capricor Therapeutics provides regulatory update on Deramiocel BLA for Duchenne Muscular Dystrophy ($7.68, 0.00)

• 09:27 AM ET Jun 20, 2025
  

  Capricor Therapeutics announces 4-year data from HOPE-2 open-label extension study of Deramiocel in duchenne muscular dystrophy ($11.94, 0.00)

• 09:08 AM ET Jun 17, 2025
  

  Capricor Therapeutics confirms FDA Orphan Drug Designation for BMD and notes regulatory progress for DMD program ($12.38, 0.00)

• 05:57 PM ET Jun 13, 2025
  

  FDA grants orphan drug designation to deramiocel for Becker muscular dystrophy ($11.78, 0.00)